...
首页> 外文期刊>Journal of Clinical Oncology >Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
【24h】

Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.

机译:I / II期研究联合使用粒细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子来动员造血祖细胞。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To study the toxicity and efficacy of combined granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) administration for mobilization of hematopoietic progenitor cells (HPCs). MATERIALS AND METHODS: Cohorts of a minimum of five patients each were treated subcutaneously as follows: G-CSF 5 micrograms/kg on days 1 to 12 and GM-CSF at .5, 1, or 5 micrograms/kg on days 7 to 12 (cohorts 1, 2, and 3); GM-CSF 5 micrograms/kg on days 1 to 12 and G-CSF 5 micrograms/kg on days 7 to 12 (cohort 4); and G-CSF and GM-CSF 5 micrograms/kg each on days 1 to 12 (cohort 5). Ten-liter aphereses were performed on days 1 (baseline, pre-CSF), 5, 7, 11, and 13. Colony assays for granulocyte-macrophage colony-forming units (CFU-GM) and erythroid burst-forming units (BFU-E) were performed on each harvest. RESULTS: The principal toxicities were myalgias, bone pain, fever, nausea, and mild thrombocytopenia, but none was dose-limiting. Four days of treatment with eitherG-CSF or GM-CSF resulted in dramatic and sustained increases in the numbers of CFU-GM per kilogram collected per harvest that represented 35.6 +/- 8.9- and 33.7 +/- 13.0-fold increases over baseline, respectively. This increment was attributable both to increased numbers of mononuclear cells collected per 10-L apheresis and to increased concentrations of progenitors within each collection. The administration of G-CSF to patients already receiving GM-CSF (cohort 4) caused the HPC content to surge to nearly 80-fold the baseline (P = .024); the reverse sequence, ie, the addition of GM-CSF to G-CSF, was less effective. The CFU-GM content of the baseline aphereses correlated with the maximal mobilization achieved (r = .74, P = .001). CONCLUSION: Combined G-CSF and GM-CSF administration effectively and predictably mobilizes HPCs and facilitates apheresis.
机译:目的:研究粒细胞集落刺激因子(G-CSF)和粒细胞巨噬细胞集落刺激因子(GM-CSF)联合给药对动员造血祖细胞(HPCs)的毒性和功效。材料与方法:至少对五名患者进行了如下皮下治疗:第1至12天G-CSF为5微克/千克,第7至12天为GM,CSF为0.5、1,或5微克/千克。 (队列1、2和3);在第1至12天时GM-CSF 5微克/千克,在第7至12天时G-CSF 5微克/千克(群组4);在第1至12天时,G-CSF和GM-CSF分别为5微克/千克(群组5)。在第1天(基线,CSF之前),第5、7、11和13天进行10升的球菌。进行粒细胞-巨噬细胞集落形成单位(CFU-GM)和红系爆发形成单位(BFU- E)在每次收获时进行。结果:主要毒性为肌痛,骨痛,发烧,恶心和轻度血小板减少症,但均无剂量限制。用G-CSF或GM-CSF处理四天后,每收获一次所收集的每公斤CFU-GM数量急剧而持续地增加,代表比基线增加35.6 +/- 8.9-和33.7 +/- 13.0倍,分别。这种增加既可归因于每10 L血液采血术收集的单核细胞数量增加,又归因于每个收集物中祖细胞浓度的增加。已接受GM-CSF的患者服用G-CSF(队列4)导致HPC含量飙升至基线的近80倍(P = .024);相反的顺序,即在G-CSF中添加GM-CSF效果不佳。基线球蛋白的CFU-GM含量与达到的最大动员相关(r = .74,P = .001)。结论:G-CSF和GM-CSF联合给药可有效且可预测地调动HPC并促进血液分离。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号